Results 151 to 160 of about 2,179,427 (282)

New treatments for hepatorenal syndrome [PDF]

, 2000
Vicente Arroyo
openalex   +1 more source

Update on hepatorenal Syndrome: Definition, Pathogenesis, and management.

Arab Journal of Gastroenterology, 2022
E. Habas, A. Ibrahim, Moaz O Moursi, Bara A. Shraim, Mohamed E. ELgamal, Abdelnaser Elzouki   +5 more
semanticscholar   +1 more source

Recompensation of Liver Cirrhosis by TIPS Reduces Epithelial Cell Death Markers, Translating Into Improved Clinical Outcome

Liver International, Volume 45, Issue 4, April 2025.
ABSTRACT Background and Aims Portal hypertension is the main pathophysiological driver of decompensation in patients with liver cirrhosis. Epithelial cell death markers, m30 and m65, correlate with hepatic injury and predict outcomes across various stages of liver disease.
Felix Piecha, Beatrice‐Victoria Jahn, Johannes Köntopf, Anja Koop, Ann‐Kathrin Ozga, Amirah Al‐Jawazneh, Aenne Harberts, Christoph Riedel, Peter Buggisch, Daniel Benten, Peter Hübener, Gerhard Adam, Samuel Huber, Ansgar W. Lohse, Peter Bannas, Johannes Kluwe   +15 more
wiley   +1 more source

Improving prognosis in hepatorenal syndrome [PDF]

, 2000
P. Aiden McCormick
openalex   +1 more source

Safety of Anticoagulation When Undergoing Endoscopic Variceal Ligation: A Systematic Review and Meta‐Analysis

Liver International, Volume 45, Issue 4, April 2025.
ABSTRACT Introduction The safety of continuing anticoagulation therapy during endoscopic variceal ligation (EVL) remains controversial. We performed a systematic review and meta‐analysis to evaluate the safety of anticoagulation therapy in EVL. Methods We systematically searched four electronic databases from their inception until 1 June 2024, for ...
Jing Hong Loo, Joo Wei Ethan Quek, Jun Teck Gerald Low, Wei Xuan Tay, Le Shaun Ang, Aldo J Montano‐Loza, Juan G Abraldes, Yu Jun Wong   +7 more
wiley   +1 more source

Use of Proton Pump Inhibitors Among Patients With Alcohol‐Related Cirrhosis—A Danish Nationwide Cohort Study

Liver International, Volume 45, Issue 4, April 2025.
ABSTRACT Background Use of proton pump inhibitors (PPIs) may have adverse effects in patients with alcohol‐related cirrhosis (ALD cirrhosis), but PPIs continue to be used by many patients. Aims We aimed to describe the prevalence and incidence of PPI use from filled prescriptions among patients with ALD cirrhosis and to identify predictors of PPI ...
Marine Sølling Ramsing, Morten Daniel Jensen, Peter Jepsen   +2 more
wiley   +1 more source

Alcohol Use Disorder Following Bariatric Surgery Leading to Cirrhosis and Hepatorenal Syndrome

Annals of Internal Medicine: Clinical Cases
The rise in metabolic surgeries for obesity has increased concerns regarding post-surgical alcohol use disorder (AUD). We present a case of a 51-year-old woman who developed AUD and subsequent alcohol-related cirrhosis after Roux-en-Y gastric bypass ...
Jenna M. Davison, James F. Howick V, Neel Shah   +2 more
doaj   +1 more source

Hepatorenal Syndrome-Novel Insights into Diagnostics and Treatment. [PDF]

Int J Mol Sci, 2023
Badura K, Frąk W, Hajdys J, Majchrowicz G, Młynarska E, Rysz J, Franczyk B.   +6 more
europepmc   +1 more source

SEVERE TRAUMA TO THE LIVER WITH “HEPATORENAL SYNDROME”

, 1942
H.J. McCorkle, Frederick S. Howard
openalex   +2 more sources

New challenge of hepatorenal syndrome: Prevention and treatment [PDF]

, 2001
F. Lennie Wong, Laurence M. Blendis
openalex   +1 more source